Skip to content
MarketScale
‹ Back to IndustriesHealthcare

TECHNOLOGY READINESS ASSESSMENTS AND MITIGATIONS

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development. Integrating technology readiness reviews into the product…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development.

Integrating technology readiness reviews into the product development process enables actionable processes that reduce project risk. This helps to avoid project delays, potential budgetary concerns, or the pressure to make design/feature compromises.

To determine whether a potential product has adequate technical maturity to effectively launch formal product development, the following steps should be considered:

  • Determine the stage of maturity of the current technology
  • Understand the implications of technology and project risks
  • Model, take measurements and analyze to decide whether core technology is capable of meeting the product requirements
  • Demonstrate that the device can provide adequate performance over the expected range of conditions
  • Determine whether the technology can scale to volume manufacturing and distribution

Evaluations begin with an objective review of each core technology critical to the operability of the device that may delay or prohibit market introduction.

This may involve proving whether core technology is adequate for use in a particular application. For example, does the new sensor being developed operate over the variety of conditions needed? Will environmental effects cause problems? Are measurements and control mechanisms adequate to provide safe and effective outcomes? Are there manufacturing difficulties in achieving the needed tolerances? These and other questions are explored, and appropriate efforts made, to bring the technology readiness level to the point that justifies moving the project to its subsequent phases.

Technology Readiness Assessment Tailored to Medical Devices

At Sunrise Labs, we implement a rigorous Technology Readiness Assessment customized specifically for medical devices. By analyzing the maturity of the technologies and the risk that each stage incurs, our assessment determines what challenges must be overcome in order for a device to be successfully engineered and commercialized.

We then improve the Technology Readiness through our feasibility Phase 0 process to prepare for a successful development effort.

To learn more about our process, check out our video on Technology Readiness.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic have entered into a 10-year alliance focusing on ambient AI and its integration into electronic health records (EHR). This partnership aims to enhance healthcare delivery systems and streamline clinical processes through advanced technology.

  • 01Siemens Healthineers and Cleveland Clinic have formed a 10-year partnership to explore ambient AI in healthcare.
  • 02The alliance focuses on transforming electronic health records (EHR) with the integration of new AI technologies.
  • 03The partnership aims to improve healthcare delivery and streamline clinical processes.

Aug 9, 2026

A Physician Entrepreneur's Journey in Specialty Care Expansion - Dr. Joe Pazona, CEO of VirtuCare

Dr. Joe Pazona shares insights into his journey as a physician entrepreneur focusing on specialty care expansion. He highlights the challenges and strategies involved in growing a healthcare business. The discussion offers valuable lessons for other healthcare professionals looking to innovate and expand in their practices.

  • 01A physician entrepreneur focuses on specialty care expansion.
  • 02Innovative strategies are necessary for growth in healthcare businesses.
  • 03Lessons from healthcare leaders can help others in the industry.

Aug 8, 2026

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512